⌘K

Login Start Free

Home/Filings/4/0001250853-21-000029

4//SEC Filing

Liu Nanxi 4

Accession 0001250853-21-000029

CIK 0001561743other

View on SEC.gov Company Profile

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 2:06 PM ET

Size

5.1 KB

Accession

0001250853-21-000029

Insider Transaction Report

Form 4

Period: 2020-02-05

Kindred Biosciences, Inc.KIN

Director

Transactions

Award
Stock Option (right to buy)
2021-02-05+48,000→ 48,000 total
Exercise: $5.08Exp: 2031-02-04→ Common Stock (48,000 underlying)

Footnotes (1)

[F1]The option will vest in four equal quarterly installments from the option grant date.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Kindred Biosciences, Inc.

CIK 0001561743

Entity typeother

Related Parties

1

filerCIK 0001818497

Filing Metadata

Form type: 4
Filed: Feb 8, 7:00 PM ET
Accepted: Feb 9, 2:06 PM ET
Size: 5.1 KB

View on SEC.gov